跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NIGHTTIME PAIN RELIEF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NIGHTTIME PAIN RELIEF
Authorized
STANDARD
NIGHTTIME PAIN RELIEF
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
dec1061a95ccbff5
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
dec1061a95ccbff5
Drug Approval Canada Name
NIGHTTIME PAIN RELIEF
Product Name
NIGHTTIME PAIN RELIEF
Status
Dormant
Status Date
2022-08-06
Original Market Date
2017-10-31
Din
02424630
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.04.92
Atc Original
M01AE51 IBUPROFEN, COMBINATIONS
Atc Name
m 01 ae 51
Aig Number
0252788001
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
DIPHENHYDRAMINE HYDROCHLORIDE
25 MG
IBUPROFEN (IBUPROFEN POTASSIUM, IBUPROFEN)
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
dec1061a95ccbff5
Type
Standard
Back to Health Canada Approvals